S.Manoj Kumar Reddy's Insider Trades & SAST Disclosures
S.Manoj Kumar Reddy's most recent trade in Concord Drugs Ltd. was a Acquisition of 171,133 Equity Shares done at an average price of Rs. 24.8 . Disclosure was reported to the exchange on Oct. 30, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
S.Manoj Kumar Reddy's has made SAST transactions in Concord Drugs Ltd. recently where a Acquisition of 342,266 shares done . Disclosure was reported to the exchange on Oct. 30, 2023.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Drugs | S Manoj Kumar Reddy & PACs | Promoter | Acquisition | 31 Oct 2023 | 342,266 | 5,540,649 (55.40%) | 3.52% | - | 27 Oct 2023 27 Oct 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S.Manoj Kumar Reddy | Promoter & Director | Acquisition | 30 Oct 2023 | 171,133 | 1,628,125 (16.28%) | 1.84% | 24.8 | 4,235,542 | 27 Oct 2023 27 Oct 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S.Manoj Kumar Reddy | Promoter & Director | Disposal | 30 Oct 2023 | 171,133 | 0 (0%) | 1.84% | 24.8 | 4,235,542 | 27 Oct 2023 27 Oct 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S Manoj Kumar Reddy & PACs | Promoter | Acquisition | 17 Oct 2023 | 342,264 | 5,198,383 (53.83%) | 3.54% | - | 12 Oct 2023 12 Oct 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S.Manoj Kumar Reddy | Promoter & Director | Disposal | 14 Oct 2023 | 171,132 | 171,133 (0%) | 1.84% | 24.8 | 4,235,517 | 12 Oct 2023 12 Oct 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S.Manoj Kumar Reddy | Promoter & Director | Acquisition | 14 Oct 2023 | 171,132 | 1,456,992 (15.09%) | 1.84% | 24.8 | 4,235,517 | 12 Oct 2023 12 Oct 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S Manoj Kumar Reddy | Promoter | Acquisition | 31 Mar 2023 | 285,860 | 1,285,860 (13.80%) | 3.07% | - | 28 Mar 2023 28 Mar 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S. Manoj Kumar Reddy | Promoter & Director | Acquisition | 30 Sep 2021 | 223,277 | 1,000,000 (11.44%) | 2.55% | 0 | 0 | 20 Sep 2021 28 Sep 2021 |
Insider Trading | Equity Shares | Gift |
| Concord Drugs | S Manoj Kumar Reddy | Promoter | Acquisition | 01 Oct 2021 | 223,277 | 1,000,000 (11.44%) | 2.56% | - | 24 Sep 2021 28 Sep 2021 |
SAST (29(2)) | - | Off Market | |
| Concord Drugs | S. Manoj Kumar Reddy | Promoter & Director | Acquisition | 22 Sep 2021 | 72,529 | 776,723 (8.88%) | 0.83% | 27.5 | 1,996,266 | 20 Sep 2021 21 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | S Manoj Kumar Reddy | Promoter | Acquisition | 22 Sep 2021 | 72,529 | 776,723 (8.88%) | 0.82% | - | 20 Sep 2021 21 Sep 2021 |
SAST (29(2)) | - | Market | |
| Concord Drugs | S. Manoj Kumar Reddy | Promoter & Director | Acquisition | 16 Sep 2021 | 39,194 | 704,194 (8.06%) | 0.45% | 26.2 | 1,026,394 | 31 Aug 2021 14 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | S Manoj Kumar Reddy | Promoter | Acquisition | 17 Sep 2021 | 39,194 | 704,194 (8.06%) | 0.45% | - | 31 Aug 2021 14 Sep 2021 |
SAST (29(2)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.